THE KOREA REGENERATIVE MEDICINE GUIDE
Conditions & evidence
Acute myeloid leukemia and transplantation
Why donor blood-forming cells may be considered after AML treatment, and what determines suitability.
“Use this guide to frame clear, indication-specific questions for your specialist consultation.”
PATIENT EVIDENCE & CONSULTATION GUIDE
Category: Conditions & evidence · Editorial Review: Updated 20 October 2026 · 3 minute read
Where transplant fits
Acute myeloid leukemia is a cancer of developing blood cells. A donor hematopoietic stem cell transplant may be part of treatment for selected patients, often after treatment has reduced the leukemia. It is an intensive hematology pathway, not the same intervention as a wellness infusion or an injection of cells obtained from fat.
The decision is individualized
The discussion should include the leukemia’s genetic findings, response to initial therapy, measurable residual disease testing when applicable, and the estimated risk of recurrence. General health, organ function, prior infections and the availability of a suitable donor also matter. Age alone does not tell the entire story, but transplant can be inappropriate when its burdens exceed the likely benefit.
What to bring to a Korean center
Request the pathology report, bone marrow results, molecular and chromosome testing, chemotherapy dates, transfusion history and recent infection records. Ask the receiving center to review the actual records before travel. A statement that the hospital offers stem cell treatment does not establish that it operates the AML transplant program you need.
Questions for the transplant consultation
Ask why transplant is recommended now, what alternatives exist, which donor options are being considered and what happens if leukemia remains detectable. Request an explanation of relapse risk separately from complications caused by treatment. The written plan should identify the inpatient team, expected monitoring milestones and how the Korean and home-country hematologists will coordinate follow-up.
Continue exploring
- Acute lymphoblastic leukemia and transplantation
- Multiple myeloma and autologous transplant
- Non-Hodgkin lymphoma and stem cell transplant
- Prepare your consultation checklist
Sources & further reading
Read alongside your treating specialist’s advice. Clinical eligibility, exact products and treatment plans require individual assessment.
CONTINUE YOUR PREPARATION
Prepare for your clinical conversation.
Combine the questions in this guide with our 12-point consultation checklist or explore Seoul clinic profiles.
CELLARIUM
Knowledge before possibility.
Cellarium is an independent editorial guide to regenerative medicine and stem cell consultations in South Korea. It does not provide medical advice, diagnosis, or treatment, and is not affiliated with any clinic or hospital.
© 2026 Cellarium — The Korea Regenerative Medicine Guide. Educational reference only; always consult a qualified specialist.